Vascular endothelial growth factor (VEGF) in breast cancer: Comparison of plasma, serum, and tissue VEGF and microvessel density and effects of tamoxifen

Cancer Research

Volumn 60, Issue 11, 2000, Pages 2898-2905

  Adams, Jacqueline ^a   Carder, Pauline J ^a   Downey, Sarah ^a   Forbes, Mary A ^a   MacLennan, Kenneth ^a   Allgar, Victoria ^a   Kaufman, Sarah ^a   Hallam, Susan ^a   Bicknell, Roy ^b   Walker, James J ^a   Cairnduff, Fiona ^a   Selby, Peter J ^a   Perren, Timothy J ^a   Lansdown, Mark ^a   Banks, Rosamonde E ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TAMOXIFEN; VASCULOTROPIN;

ADULT; AGED; ARTICLE; BLOOD LEVEL; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER REGRESSION; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; METASTASIS; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; PROTEIN DETERMINATION; TISSUE LEVEL;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS, HORMONAL; BLOOD PLATELETS; BREAST NEOPLASMS; DISEASE PROGRESSION; ENDOTHELIAL GROWTH FACTORS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOKINES; MICROCIRCULATION; MIDDLE AGED; NEOPLASM METASTASIS; REMISSION INDUCTION; TAMOXIFEN; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0034212632     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (69)

1. Folkman, J. The role of angiogenesis in tumor growth. Semin. Cancer Biol., 3: 65-71, 1992.
2. Ferrara, N. Vascular endothelial growth factor. Eur. J. Cancer, 32A: 2413-2422, 1996.
3. Weidner, N., Semple, J. P., Welch, W. R., and Folkman, J. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N. Engl. J. Med., 324: 1-8, 1991.
4. Gasparini, G., and Harris, A. L. Clinical importance of the determination of tumor angiogenesis in breast carcinoma: much more than a new prognostic tool. J. Clin. Oncol., 13: 765-782, 1995.
5. Heimann, R., Ferguson, D., Powers, C., Recant, W. M., Weichselbaum, R. R., and Hellman, S. Angiogenesis as a predictor of long-term survival for patients with node-negative breast cancer. J. Natl. Cancer Inst., 88: 1764-1769, 1996.
6. Gasparini, G., Fox, S. B., Verderio, P., Bonoldi, E., Bevilacqua, P., Boracchi, P., Dante, S., Marubini, E., and Harris, A. L. Determination of angiogenesis adds information to estrogen receptor status in predicting the efficacy of adjuvant tamoxifen in node-positive breast cancer patients. Clin. Cancer Res., 2: 1191-1198, 1996.
7. Yoshiji, H., Gomez, D. E., Shibuya, M., and Thorgeirsson, U. P. Expression of vascular endothelial growth factor, its receptor, and other angiogenic factors in human breast cancer. Cancer Res., 56: 2013-2016, 1996.
8. Anan, K., Morisaki, T., Katano, M., Ikubo, A., Kitsuki, H., Uchiyama, A., Kuroki, S., Tanaka, M., and Torisu, M. Vascular endothelial growth factor and platelet-derived growth factor are potential angiogenic and metastatic factors in human breast cancer. Surgery, 119: 333-339, 1996.
9. Brown, L. F., Berse, B., Jackman, R. W., Tognazzi, K., Guidi, A. J., Dvorak, H. F., Senger, D. R., Connolly, J. L., and Schnitt, S. J. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer. Hum. Pathol., 26: 86-91, 1995.
10. Lee, A. H. S., Dublin, E. A., Bobrow, L. G., and Poulsom, R. Invasive tabular and invasive ductal carcinoma of the breast show distinct patterns of vascular endothelial growth factor expression and angiogenesis. J. Pathol., 185: 394-401, 1998.
11. Anan, K., Morisaki, T., Katano, M., Ikubo, A., Tsukahara, Y., Uchiyama, A., Kuroki, S., Tanaka, M., and Torisu, M. Preoperative assessment of tumor angiogenesis by vascular endothelial growth factor mRNA expression in homogenate samples of breast carcinoma: fine-needle aspirates vs. resection samples. J. Surg. Oncol., 66: 257-263, 1997.
12. Anan, K., Morisaki, T., Katano, M., Ikubo, M., Tsukahara, Y., Kojima, M., Uchiyama, A., Kuroki, S., Torisu, M., and Tanaka, M. Assessment of c-erbB2 and vascular endothelial growth factor mRNA expression in fine-needle aspirates from early breast carcinomas: pre-operative determination of malignant potential. Eur. J. Surg. Oncol., 24: 28-33, 1998.
13. Guidi, A. J., Schnitt, S. J., Fischer, L., Tognazzi, K., Harris, J. R., Dvorak, H. F., and Brown, L. F. Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in patients with ductal carcinoma in situ of the breast. Cancer (Phila.), 80: 1945-1953, 1997.
14. Toi, M., Kondo, S., Suzuki, H., Yamamoto, Y., Inada, K., Imazawa, T., Taniguchi, T., and Tominaga, T. Quantitative analysis of vascular endothelial growth factor in primary breast cancer. Cancer (Phila.), 77: 1101-1106, 1996.
15. Obermair, A., Kucera, E., Mayerhofer, K., Speiser, P., Seifert, M., Czerwenka, K., Kaider, A., Leodolter, S., Kainz, C., and Zeillinger, R. Vascular endothelial growth factor (VEGF) in human breast cancer: correlation with disease-free survival. Int. J. Cancer, 74: 455-458, 1997.
16. Toi, M., Hoshina, S., Takayanagi, T., and Tominaga, T. Association of vascular endothelial growth factor expression with tumor angiogenesis and with early relapse in primary breast cancer. Jpn. J. Cancer Res., 85: 1045-1049, 1994.
17. Eppenberger, U., Kueng, W., Schlaeppi, J-M., Roesel, J. L., Benz, C., Mueller, H., Matter, A., Zuber, M., Luescher, K., Litschgi, M., Schmitt, M., Foekens, J. A., and Eppenberger-Castori, S. Markers of tumor angiogenesis and proteolysis independently define high- and low-risk subsets of node-negative breast cancer patients. J. Clin. Oncol., 16: 3129-3136, 1998.
18. Gasparini, G., Toi, M., Gion, M., Verderio, P., Dittadi, R., Hanatani, M., Matsubara, I., Vinante, O., Bonoldi, E., Boracchi, P., Gatti, C., Suzuki, H., and Tominaga, T. Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma. J. Natl. Cancer Inst., 89: 139-147, 1997.
19. Linderholm, B., Tavelin, B., Grankvist, K., and Henriksson, R. Vascular endothelial growth factor is of high prognostic value in node-negative breast carcinoma. J. Clin. Oncol., 16: 3121-3128, 1998.
20. Kondo, S., Asano, M., Matsuo, K., Ohmori, I., and Suzuki, H. Vascular endothelial growth factor/vascular permeability factor is detectable in the sera of tumor-bearing mice and cancer patients. Biochim. Biophys. Acta, 1221: 211-214, 1994.
21. Salven, P., Maenpaa, H., Orpana, A., Alitalo, K., and Joensuu, H. Serum vascular endothelial growth factor is often elevated in disseminated cancer. Clin. Cancer Res., 3: 647-651, 1997.
22. Kraft, A., Weindel, K., Ochs, A., Marth, C., Zmija, J., Schumacher, P., Unger, C., Marme, D., and Gastl, G. Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease. Cancer (Phila.), 85: 178-187, 1999.
23. Yamamoto, Y., Toi, M., Kondo, S., Matsumoto, T., Suzuki, H., Kitamura, M., Tsuruta, K., Taniguchi, T., Okamoto, A., Mori, T., Yoshida, M., Ikeda, T., and Tominaga, T. Concentrations of vascular endothelial growth factor in the sera of normal controls and cancer patients. Clin. Cancer Res., 2: 821-826, 1996.
24. Salven, P., Perhoniemi, V., Tykka, H., Maenpaa, H., and Joensuu, H. Serum VEGF levels in women with a benign breast tumor or breast cancer. Breast Cancer Res. Treat., 53: 161-166, 1999.
25. Tempfer, C., Obermair, A., Hefler, L., Haeusler, G., Gitsch, G., and Kainz, C. Vascular endothelial growth factor serum concentrations in ovarian cancer. Obstet. Gynecol., 92: 360-363, 1998.
26. Yamamoto, S., Konishi, I., Mandai, M., Kuroda, H., Komatsu, T., Nanbu, K., Sakahara, H., and Mori, T. Expression of vascular endothelial growth factor (VEGF) in epithelial ovarian neoplasms: correlation with clinicopathology and patient survival, and analysis of serum VEGF levels. Br. J. Cancer, 76: 1221-1227, 1997.
27. Chen, C. A., Cheng, W. F., Lee, C. N., Chen, T. M., Kung, C. C., Hsieh, F. J., and Hsieh, C. Y. Serum vascular endothelial growth factor in epithelial ovarian neoplasms: correlation with patient survival. Gynecol. Oncol., 74: 235-240, 1999.
28. Banks, R. E., Forbes, M. A., Kinsey, S. E., Stanley, A., Ingham, E., Walters, C., and Selby, P. J. Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology. Br. J. Cancer, 77: 956-964, 1998.
29. Webb, N. J. A., Bottomley, M. J., Watson, C. J., and Brenchley, P. E. C. Vascular endothelial growth factor (VEGF) is released from platelets during blood clotting: implications for measurement of circulating VEGF levels in clinical disease. Clin. Sci., 94: 395-404, 1998.
30. Verheul, H. M. W., Hoekman, K., Luykx-de Bakker, S., Eekman, C. A., Folman, C. C., Broxterman, H. J., and Pinedo, H. M. Platelet: transporter of vascular endothelial growth factor. Clin. Cancer Res., 3: 2187-2190, 1997.
31. Katoh, O., Tauchi, H., Kawaishi, K., Kimura, A., and Satow, Y. Expression of the vascular endothelial growth factor (VEGF) receptor gene. KDR, in hematopoietic cells and inhibitory effect of VEGF on apoptotic cell death caused by ionizing radiation. Cancer Res., 55: 5687-5692, 1995.
32. Freeman, M. R., Schneck, F. X., Gagnon, M. L., Corless, C., Soker, S., Niknejad, K., Peoples, G. E., and Klagsbrun, M. Peripheral blood T lymphocytes and lymphocytes infiltrating human cancers express vascular endothelial growth factor: a potential role for T cells in angiogenesis. Cancer Res., 55: 4140-4145, 1995.
33. Wartiovaara, U., Salven, P., Mikkola, H., Lassila, R., Kaukonen, J., Joukov, V., Orpana, A., Ristimaki, A., Heikinheimo, M., Joensuu, H., Alitalo, K., and Palotie, A. Peripheral blood platelets express VEGF-C and VEGF which are released during platelet activation. Thromb. Haemost., 80: 171-175, 1998.
34. Möhle, R., Green, D., Moore, M. A. S., Nachman, R. L., and Rafii, S. Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets. Proc. Natl. Acad. Sci. USA, 94: 663-668, 1997.
35. Gaudry, M., Brgerie, O., Andrieu, V., El Benna, J., Pocidalo, M. A., and Hakim, J. Intracellular pool of vascular endothelial growth factor in human neutrophils. Blood, 90: 4153-4161, 1997.
36. Turley, H., Scott, P. A. E., Watts, V. M., Bicknell, R., Harris, A. L., and Gatter, K. C. Expression of VEGF in routinely fixed material using a new monoclonal antibody VG1. J. Pathol., 186: 313-318, 1998.
37. Sobin, L. H., and Wittekind, C., (eds.) UICC-TNM Classification of Malignant Tumours, 5th ed. New York: Wiley-Liss Inc., 1997.
38. Elston, C. W., and Ellis, I. O. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology, 19: 403-410, 1991.
39. Zhang, L., Scott, P. A. E., Turley, H., Leek, R., Lewis, C. E., Gatter, K. C., Harris, A. L., Mackenzie, I. Z., Rees, M. C. P., and Bicknell, R. Validation of anti-vascular endothelial growth factor (anti-VEGF) antibodies for immunohistochemical localization of VEGF in tissue sections: expression of VEGF in the human endometrium. J. Pathol., 185: 402-408, 1998.
40. Vermeulen, P. B., Gasparini, G., Fox, S. B., Toi, M., Martin, L., McCulloch, P., Pezzella, F., Viale, G., Weidner, N., Harris, A. L., and Dirix, L. Y. Quantification of angiogenesis in solid human tumours: an International consensus on the methodology and cnteria of evaluation. Eur. J. Cancer, 32A: 2474-2484, 1996.
41. Chung, H. C., Rha, S. Y., Ahn, J. B., Shim, K. Y., Yoo, N. C., Kim, J. H., Roh, J. K., Lee, K. S., Min, J. S., Kim, B. S., and Kim, J. J. Menstrual state should be considered in determining sero-positivity of soluble angiogenic factors in breast cancer. Int. J. Mol. Med., 2: 465-470, 1998.
42. Hyodo, I., Doi, T., Endo, H., Hosokawa, Y., Nishikawa, Y., Tanimizu, M., Jinno, K., and Kotani, Y. Clinical significance of plasma vascular endothelial growth factor in gastrointestinal cancer. Eur. J. Cancer, 13: 2041-2045, 1998.
43. Duque, J. L., Loughlin, K. R., Adam, R. M., Kantoff, P. W., Zurakowski, D., and Freeman, M. R. Plasma levels of vascular endothelial growth factor are increased in patients with metastatic prostate cancer. Urology, 54: 523-527, 1999.
44. Crichton, M. B., Nichols, J. E., Zhao, Y., Bulun, S. E., and Simpson, E. R. Expression of transcripts of interleukin-6 and related cytokines by human breast tumors, breast cancer cells, and adipose stromal cells. Mol. Cell. Endocrinol., 118: 215-220, 1996.
45. Hsich, G., Kenney, K., Gibbs, C. J., Lee, K. H., and Harrington, M. G. The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies [see comments]. N. Engl. J. Med., 335: 924-930, 1996.
46. Salgado, R., Vermeulen, P. B., Benoy, I., Weytjens, R., Huget, P., Van Marck, E., and Dirix, L. Y. Platelet number and interleukin-6 correlate with VEGF but not with bFGF serum levels of advanced cancer patients. Br. J. Cancer, 80: 892-897, 1999.
47. Gunsilius, E., and Gastl, G. Platelets and VEGF blood levels in cancer patients. Br. J. Cancer, 81: 184-186, 1999.
48. O'Byrne, K. J., Dobbs, N., Propper, D., Smith, K., and Harris, A. L. Vascular endothelial growth factor, platelet counts, and prognosis in renal cancer. Lancet, 353: 1494-1495, 1999.
49. Salven, P., Orpana, A., and Joensuu, H. Leukocytes and platelets of patients with cancer contain high levels of vascular endothelial growth factor. Clin. Cancer Res., 5: 487-491, 1999.
50. Pinedo, H. M., Verheul, H. M. W., D'Amato, R. J., and Folkman, J. Involvement of platelets in tumour angiogenesis? Lancet, 352: 1775-1777, 1998.
51. Dunst, J., Pigorsch, S., Hansgen, G., Hintner, I., Lautenschlager, C., and Becker, A. Low hemoglobin is associated with increased serum levels of vascular endothelial growth factor (VEGF) in cancer patients. Does anemia stimulate angiogenesis? Strahlenther. Onkol., 175: 93-96, 1999.
52. Heer, K., Kumar, H., Speirs, V., Greenman, J., Drew, P. J., Fox, J. N., Carleton, P. J., Monson, J. R. T., and Kerin, M. J. Vascular endothelial growth factor in premenopausal women - indicator of the best time for breast cancer surgery? Br. J. Cancer, 78: 1203-1207, 1998.
53. Agrawal, R., Conway, G. S., Sladkevicius, P., Payne, N. N., Bekir, J., Campbell, S., Tan, S. L., and Jacobs, H. S. Serum vascular endothelial growth factor (VEGF) in the normal menstrual cycle: association with changes in ovarian and uterine Doppler blood flow. Clin. Endocrinol., 50: 101-106, 1999.
54. Benoy, I., Vermeulen, P., Wuyts, H., and Dirix, L. Vascular endothelial cell growth factor (VEGF) serum concentrations change according to the phase of the menstrual cycle. Eur. J. Cancer, 34: 1298-1299, 1998.
55. Lonning, P. E., Hall, K., Aakvaag, A., and Lien, E. A. Influence of tamoxifen on plasma levels of insulin-like growth factor I and insulin-like growth factor binding protein I in breast cancer patients. Cancer Res., 52: 4719-4723, 1992.
56. Pollak, M., Costantino, J., Polychronakos, C., Blauer, S-A., Guyda, H., Redmond, C., Fisher, B., and Margolese, R. Effect of tamoxifen on serum insulinlike growth factor I levels in stage 1 breast cancer patients. J. Natl. Cancer Inst., 82: 1693-1697, 1999.
57. Hyder, S. M., Murthy, L., and Stancel, G. M. Progestin regulation of vascular endothelial growth factor in human breast cancer cells. Cancer Res., 58: 392-395, 1998.
58. Huang, J. C., Liu, D. Y., and Dawood, M. Y. The expression of vascular endothelial growth factor isoforms in cultured human endometrial stromal cells and its regulation by 17β-oestradiol. Mol. Hum. Reprod., 4: 603-607, 1998.
59. Cullinan-Bove, K., and Koos, R. D. Vascular endothelial growth factor/vascular permeability factor expression in the rat uterus: rapid stimulation by estrogen correlates with estrogen-induced increases in uterine capillary permeability and growth. Endocrinology, 133: 829-837, 1993.
60. Shifren, J. L., Tseng, J. F., Zaloudek, C. J., Ryan, I. P., Meng, Y. G., Ferrara, N., Jaffe, R. B., and Taylor, R. N. Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis. J. Clin. Endocrinol. Metab., 81: 3112-3118, 1996.
61. Charnock-Jones, D. S., Sharkey, A. M., Rajput-Williams, J., Burch, D., Schofield, J. P., Fountain, S. A., Boocock, C. A., and Smith, S. K. Identification and localization of alternatively spliced mRNAs for vascular endothelial growth factor in human uterus and estrogen regulation in endometrial carcinoma cell lines. Biol. Reprod., 48: 1120-1128, 1993.
62. Ruohola, J. K., Valve, E. M., Karkkainen, M. J., Joukov, V., Alitalo, K., and Harkonen, P. L. Vascular endothelial growth factors are differentially regulated by steroid hormones and antiestrogens in breast cancer cells. Mol. Cell. Endocrinol., 149: 29-40, 1999.
63. Hyder, S. M., Stancel, G. M., Chiappetta, C., Murthy, L., Boettger-Tong, H. L., and Makela, S. Uterine expression of vascular endothelial growth factor is increased by estradiol and tamoxifen. Cancer Res., 56: 3954-3960, 1996.
64. Zhao, Y., Hague, S., Manek, S., Zhang, L., Bicknell, R., and Rees, M. C. PCR display identifies tamoxifen induction of the novel angiogenic factor adrenomedullin by a non estrogenic mechanism in the human endometrium. Oncogene, 16: 409-415, 1999.
65. Gagliardi, A. R., Hennig, B., and Collins, D. C. Antiestrogens inhibit endothelial cell growth stimulated by angiogenic-growth factors. Anticancer Res., 16: 1101-1106, 1996.
66. Kedar, R. P., Bourne, T. H., Powles, T. J., Collins, W. P., Ashley, S. E., Cosgrove, D. O., and Campbell, S. Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomised breast cancer prevention trial. Lancet, 343: 1318-1321, 1994.
67. Gasparini, G., Weidner, N., Bevilacqua, P., Maluta, S., Dalla Palma, P., Caffo, O., Barbareschi, M., Boracchi, P., Marubini, E., and Pozza, F. Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma. J. Clin. Oncol., 12: 454-466, 1994.
68. Horak, E. R., Leek, R., Klenk, N., Le Jeune, S., Smith, K., Stuart, N., Greenall, M., Stepniewska, K., and Harris, A. L. Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. Lancet, 340: 1120-1124, 1992.
69. Balsari, A., Maier, J. A. M., Colnaghi, M. I., and Menard, S. Correlation between tumor vascularity, vascular endothelial growth factor production by tumor cells, serum vascular endothelial growth factor levels, and serum angiogenic activity in patients with breast carcinoma. Lab. Investig., 79: 897-902, 1999.